PhD course on Lifestyle-related Skeletal Muscle Diseases

PhD course on Lifestyle-related Skeletal Muscle Diseases  -

On 4-8 June 2018, Department of Nutrition, Exercise & Sports (NEXS), University of Copenhagen, is hosting an international PhD course Lifestyle-related Skeletal Muscle Diseases - from Mechanism to Drug the aim of which is to provide an overview of the state-of-the-art within the content covered and to provide a forum for exchange and cross-germination of ideas and concepts between the muscle growth and muscle metabolism and their translation into drugs.


4-8 June 2018

North Campus (Nørre Campus) at University of Copenhagen
Universitetsparken 21, Copenhagen Ø 

The course includes participation in University of Copenhagen Lifestyle-Obesity-Metabolism (KU LOM) conference Trends in excellent and interdisciplinary lifestyle, obesity and metabolic research held on 7-8 June 2018.


  • David E. James, Charles Perkins Centre, University of Sydney, Sydney.
    Insulin-signaling, metabolic regulation and proteomics
  • Paul Gregorevic, Baker Heart and Diabetes Institute, Melbourne.
    Adeno-associated vira and muscle atrophy
  • Faidon Magkos, Singapore Institute of Clinical Sciences, Singapore.
    Obesity and its sequelae
  • Riki Ogasawara, Nagoya Institute of Technology.
    Rodent muscle hypertrophy models
  • Paul Verkade, Bristol University, Great Britain.
    State-of-the-art imaging in skeletal muscle
  • Atul Deshmukh, Novo Nordisk Foundation Center for Protein Research, University of Copenhagen.
    Muscle proteomics
  • Johan Ulrik Lind, Technical University of Denmark (DTU).
    Human in vitro 3D muscle models
  • Cord Brakebusch, Biotech Research and Innovation Centre (BRIC), University of Copenhagen.
    Mouse transgenics using CRISPR/Cas9
  • Lykke Sylow, Department of Nutrition Exercise and Sports (NEXS), University of Copenhagen.
    Cancer cachexia
  • Erik Richter, NEXS
    Human glucose metabolism
  • Bente Kiens, NEXS
    Human fat metabolism and insulin resistance
  • Jørgen Wojtaszewski, NEXS
    Exercise as an insulin-sensitizer
  • Sebastian Beck Jørgensen, Novo Nordisk
  • Bo Falck Hansen, Novo Nordisk
    Pharmaceutical opportunities within muscle-growth
  • Christian Pehmøller, Pfizer Boston
    Drug discovery the American way


The course is free of charge and includes lunch all days and two dinners, but does not cover travel and accommodation.

Read more and register for the course here.
Registratin deadline: 28 May 2018


Thomas Elbenhardt Jensen,